Literature DB >> 12714388

Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations.

J Prada1, B Noelle, H Baatz, C Hartmann, U Pleyer.   

Abstract

BACKGROUND/AIMS: Ultrastructural alterations in the stroma adjacent to corneal perforations have previously been reported in patients with longstanding rheumatoid arthritis. Since patients with rheumatoid arthritis often present upregulation of proinflammatory cytokines in serum and in synovial fluid, it was of interest to analyse the gene expression of these cytokines-for example, tumour necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6), in corneal samples from patients with corneal ulcerations and/or perforations associated with rheumatoid arthritis.
METHODS: Corneal samples from seven patients with corneal ulcerations and/or perforations associated with rheumatoid arthritis were collected in 4% paraformaldehyde in "RNAse-free" conditions. Paraffin sections were fixed on silan coated slides and further analysed by systematic non-radioactive in situ hybridisation, using specific gene probes for TNF-alpha and IL-6 labelled with digoxigenin (DIG). Detection of hybrids was carried out by using a commercially available DIG detection system.
RESULTS: Whereas an extended TNF-alpha gene expression could be clearly observed in the keratocytes surrounding the corneal ulcerations and/or perforations from five of the seven analysed patients, all seven patients presented clearly positive results for an extended IL-6 gene expression in the analysed tissue samples.
CONCLUSIONS: Alterations in corneal cells surrounding ulcerations and/or perforations in patients with rheumatoid arthritis may occur with implication for inflammatory processes. Upregulation of the proinflammatory cytokines TNF-alpha and IL-6 may modify the production of metalloproteinases in the corresponding cells resulting in collagenolytic corneal damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714388      PMCID: PMC1771635          DOI: 10.1136/bjo.87.5.548

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

2.  Ultrastructural alterations in the stroma adjacent to non-inflammatory corneal perforations associated with long standing rheumatoid arthritis.

Authors:  W Adachi; K Nishida; A J Quantock; S Kinoshita; Y Ishii
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

Review 3.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

4.  Detection of tumor necrosis factor alpha and interleukin 1 alpha gene expression in human lens epithelial cells.

Authors:  J Prada; T Ngo-Tu; H Baatz; C Hartmann; U Pleyer
Journal:  J Cataract Refract Surg       Date:  2000-01       Impact factor: 3.351

5.  In situ hybridization demonstration of poly-adenylated RNA sequences in formalin-fixed paraffin sections using a biotinylated oligonucleotide poly d(T) probe.

Authors:  J H Pringle; L Primrose; C N Kind; I C Talbot; I Lauder
Journal:  J Pathol       Date:  1989-08       Impact factor: 7.996

Review 6.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

7.  [Keratomalacia in rheumatoid arthritis: immunohistologic and enzyme histochemical studies].

Authors:  J G Saal; P Fritz; B Zymela; M Zierhut; H Dürk; C A Müller; U Pleyer; H J Thiel
Journal:  Z Rheumatol       Date:  1991 May-Jun       Impact factor: 1.372

8.  Ophthalmological manifestations of adult rheumatoid arthritis and cicatricial pemphigoid.

Authors:  K M Gardner; G M Rajacich; B J Mondino
Journal:  Int Ophthalmol Clin       Date:  1985

9.  Conjunctival resection for the treatment of the rheumatoid corneal ulceration.

Authors:  R S Feder; J H Krachmer
Journal:  Ophthalmology       Date:  1984-02       Impact factor: 12.079

10.  Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy.

Authors:  G N Kervick; S C Pflugfelder; R Haimovici; H Brown; E Tozman; R Yee
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

View more
  11 in total

1.  Expression of tumor necrosis factor-α and interleukin-6 in corneal cells after excimer laser ablation in Wistar rats.

Authors:  J Prada; S Schruender; T Ngo-Tu; H Baatz; C Hartmann; U Pleyer
Journal:  Eye (Lond)       Date:  2011-02-04       Impact factor: 3.775

Review 2.  [Diseases of the outer eye in rheumatoid arthritis].

Authors:  E Feist; U Pleyer
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

3.  Cellular Infiltrate in Rheumatoid Arthritis-associated Paracentral Corneal Ulceration.

Authors:  Carolyn M Kalsow; Steven S S T Ching; Ronald D Plotnik
Journal:  Ocul Immunol Inflamm       Date:  2016-08-11       Impact factor: 3.070

Review 4.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

5.  Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts.

Authors:  Alireza Mirshahi; René Hoehn; Katrin Lorenz; Christina Kramann; Holger Baatz
Journal:  J Ophthalmic Vis Res       Date:  2012-01

6.  TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.

Authors:  Ga Bin Park; Dae Young Hur; Yeong Seok Kim; Hyun-Kyung Lee; Jae Wook Yang; Daejin Kim
Journal:  J Cell Mol Med       Date:  2015-03-06       Impact factor: 5.310

7.  Corneal, Scleral, Choroidal, and Foveal Thickness in Patients with Rheumatoid Arthritis.

Authors:  Onur Gökmen; Nilüfer Yeşilırmak; Ahmet Akman; Sirel Gür Güngör; Ahmet Eftal Yücel; Hilmi Yeşil; Fatih Yıldız; Adam Sise; Vasilios Diakonis
Journal:  Turk J Ophthalmol       Date:  2017-12-25

8.  Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches.

Authors:  Madhu Sudhana Saddala; Hu Huang
Journal:  J Transl Med       Date:  2019-07-02       Impact factor: 5.531

9.  Adalimumab for refractory peripheral ulcerative keratitis.

Authors:  Miguel Cordero-Coma; Raquel Salazar Méndez; Alvaro Casado Blanco; Ana López Corral; Sara Calleja-Antolín; José M Ruiz de Morales
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-16

10.  Tofacitinib citrate for ulcerative keratitis in a patient with rheumatoid arthritis.

Authors:  Philip B Meadow; Jacqueline Nguyen; Keerthana Kesavarapu
Journal:  Case Rep Rheumatol       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.